Immunologic Effects of Maraviroc in HIV-Infected Patients with Severe CD4 Lymphopenia Starting Antiretroviral Therapy: A Sub-Study of the CADIRIS Trial

BACKGROUND: We aimed to describe the mechanisms of immunological recovery and the effects of blocking CCR5 in patients starting ART with advanced HIV-infection. METHODS: This was a sub-study of a 48 week double-blind, clinical trial where patients starting ART with CD4+ cell counts <100 cells/uL...

Descripción completa

Detalles Bibliográficos
Autores principales: Belaunzarán-Zamudio, Pablo F., Azzoni, Livio, Canaday, David H., Caro-Vega, Yanink N., Clagett, Brian, Rassool, Mohammed S, Rodriguez, Benigno, Sanne, Ian, Sereti, Irini, Sierra-Madero, Juan G., Lederman, Michael M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pathogens and Immunity 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518704/
https://www.ncbi.nlm.nih.gov/pubmed/28736763
http://dx.doi.org/10.20411/pai.v2i2.181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518704/
https://www.ncbi.nlm.nih.gov/pubmed/28736763
http://dx.doi.org/10.20411/pai.v2i2.181

Ejemplares similares